Report Detail
Global (United States, European Union and China) Colon & Rectal Carcinoma Market Research Report 2019-2025
- RnM3686035 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Colorectal cancer (CRC) is one of the “big four” tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together.
In 2019, the market size of Colon & Rectal Carcinoma is 8500 million US$ and it will reach 9880 million US$ in 2025, growing at a CAGR of 1.9% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Colon & Rectal Carcinoma.
This report studies the global market size of Colon & Rectal Carcinoma, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Colon & Rectal Carcinoma sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Bayer Healthcare
Spectrum
Novartis
Amgen
Roche
Merck
...
Market Segment by Product Type
Colon
Rectal
Market Segment by Application
Hospital
Clinic
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Colon & Rectal Carcinoma status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Colon & Rectal Carcinoma manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Colon & Rectal Carcinoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Colon & Rectal Carcinoma Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Colon
- 1.3.3 Rectal
- 1.4 Market Segment by Application
- 1.4.1 Global Colon & Rectal Carcinoma Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Colon & Rectal Carcinoma Market Size
- 2.1.1 Global Colon & Rectal Carcinoma Revenue 2014-2025
- 2.1.2 Global Colon & Rectal Carcinoma Sales 2014-2025
- 2.2 Colon & Rectal Carcinoma Growth Rate by Regions
- 2.2.1 Global Colon & Rectal Carcinoma Sales by Regions 2014-2019
- 2.2.2 Global Colon & Rectal Carcinoma Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Colon & Rectal Carcinoma Sales by Manufacturers
- 3.1.1 Colon & Rectal Carcinoma Sales by Manufacturers 2014-2019
- 3.1.2 Colon & Rectal Carcinoma Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Colon & Rectal Carcinoma Revenue by Manufacturers (2014-2019)
- 3.2.2 Colon & Rectal Carcinoma Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Colon & Rectal Carcinoma Market Concentration Ratio (CR5 and HHI)
- 3.3 Colon & Rectal Carcinoma Price by Manufacturers
- 3.4 Key Manufacturers Colon & Rectal Carcinoma Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Colon & Rectal Carcinoma Market
- 3.6 Key Manufacturers Colon & Rectal Carcinoma Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Colon Sales and Revenue (2014-2019)
- 4.1.2 Rectal Sales and Revenue (2014-2019)
- 4.2 Global Colon & Rectal Carcinoma Sales Market Share by Type
- 4.3 Global Colon & Rectal Carcinoma Revenue Market Share by Type
- 4.4 Colon & Rectal Carcinoma Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Colon & Rectal Carcinoma Sales by Application
6 United States
- 6.1 United States Colon & Rectal Carcinoma Breakdown Data by Company
- 6.2 United States Colon & Rectal Carcinoma Breakdown Data by Type
- 6.3 United States Colon & Rectal Carcinoma Breakdown Data by Application
7 European Union
- 7.1 European Union Colon & Rectal Carcinoma Breakdown Data by Company
- 7.2 European Union Colon & Rectal Carcinoma Breakdown Data by Type
- 7.3 European Union Colon & Rectal Carcinoma Breakdown Data by Application
8 China
- 8.1 China Colon & Rectal Carcinoma Breakdown Data by Company
- 8.2 China Colon & Rectal Carcinoma Breakdown Data by Type
- 8.3 China Colon & Rectal Carcinoma Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Colon & Rectal Carcinoma Breakdown Data by Company
- 9.2 Rest of World Colon & Rectal Carcinoma Breakdown Data by Type
- 9.3 Rest of World Colon & Rectal Carcinoma Breakdown Data by Application
- 9.4 Rest of World Colon & Rectal Carcinoma Breakdown Data by Countries
- 9.4.1 Rest of World Colon & Rectal Carcinoma Sales by Countries
- 9.4.2 Rest of World Colon & Rectal Carcinoma Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.1.4 Colon & Rectal Carcinoma Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Bayer Healthcare
- 10.2.1 Bayer Healthcare Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.2.4 Colon & Rectal Carcinoma Product Introduction
- 10.2.5 Bayer Healthcare Recent Development
- 10.3 Spectrum
- 10.3.1 Spectrum Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.3.4 Colon & Rectal Carcinoma Product Introduction
- 10.3.5 Spectrum Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.4.4 Colon & Rectal Carcinoma Product Introduction
- 10.4.5 Novartis Recent Development
- 10.5 Amgen
- 10.5.1 Amgen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.5.4 Colon & Rectal Carcinoma Product Introduction
- 10.5.5 Amgen Recent Development
- 10.6 Roche
- 10.6.1 Roche Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.6.4 Colon & Rectal Carcinoma Product Introduction
- 10.6.5 Roche Recent Development
- 10.7 Merck
- 10.7.1 Merck Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Colon & Rectal Carcinoma
- 10.7.4 Colon & Rectal Carcinoma Product Introduction
- 10.7.5 Merck Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Colon & Rectal Carcinoma Sales Channels
- 11.2.2 Colon & Rectal Carcinoma Distributors
- 11.3 Colon & Rectal Carcinoma Customers
12 Market Forecast
- 12.1 Global Colon & Rectal Carcinoma Sales and Revenue Forecast 2019-2025
- 12.2 Global Colon & Rectal Carcinoma Sales Forecast by Type
- 12.3 Global Colon & Rectal Carcinoma Sales Forecast by Application
- 12.4 Colon & Rectal Carcinoma Forecast by Regions
- 12.4.1 Global Colon & Rectal Carcinoma Sales Forecast by Regions 2019-2025
- 12.4.2 Global Colon & Rectal Carcinoma Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Colon & Rectal Carcinoma. Industry analysis & Market Report on Colon & Rectal Carcinoma is a syndicated market report, published as Global (United States, European Union and China) Colon & Rectal Carcinoma Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Colon & Rectal Carcinoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
